elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q40266818-FD0DE475-9CEC-4262-AE4F-2CAE22235361
Q40266818-FD0DE475-9CEC-4262-AE4F-2CAE22235361
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40266818-FD0DE475-9CEC-4262-AE4F-2CAE22235361
Efficacy and safety of tofogliflozin in Japanese patients with type 2 diabetes mellitus with inadequate glycaemic control on insulin therapy (J-STEP/INS): Results of a 16-week randomized, double-blind, placebo-controlled multicentre trial.
P2860
Q40266818-FD0DE475-9CEC-4262-AE4F-2CAE22235361
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40266818-FD0DE475-9CEC-4262-AE4F-2CAE22235361
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ca479c32ce06a0b45d94923759b3193eeb6f7a91
P2860
A novel and selective sodium-glucose cotransporter-2 inhibitor, tofogliflozin, improves glycaemic control and lowers body weight in patients with type 2 diabetes mellitus.